US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 1.500
  • +0.020+1.35%
Close Feb 26 16:00 ET
48.03MMarket Cap-0.60P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 2.258M--
--2025/Q2-- / 702.600K--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
Aug 14, 20242024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 2.258M--
--2025/Q2-- / 702.600K--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
Aug 14, 20242024/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Outlook Therapeutics Earnings Reports

  • Outlook Therapeutics | 10-Q: Q1 2025 Earnings Report

    Feb 14 17:07 ET

  • Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update

    Feb 14 08:19 ET

  • Outlook Therapeutics | 10-K/A: Annual report (Amendment)

    Jan 23 17:03 ET

  • Outlook Therapeutics | 10-K: FY2024 Annual Report

    Dec 27, 2024 16:34 ET

    • Read more

    Trending Stocks

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    NVIDIA
    NVDA
    131.280
    Tesla
    TSLA
    290.800
    Super Micro Computer
    SMCI
    51.110
    4
    Palantir
    PLTR
    89.310
    5
    Applovin
    APP
    331.000
    Log In for the Full List
    Unlock Now